SynthesisNeuropsychology review2026
A Systematic Review of Cognitive and Behavioural Symptoms in CTNNB1 Syndrome.
Synthesis in Neuropsychology review, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Genotype-phenotype characterization and functional reconstitution of pathogenic β-catenin variants from CTNNB1 syndrome patients.PLoS genetics · 2025Article
- Cognitive and Adaptive Functioning of CTNNB1 Syndrome Patients: A Comparison With Autism Spectrum Disorder and Cerebral Palsy.Journal of intellectual disability research : JIDR · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
CTNNB1 syndrome is a rare neurodevelopmental disorder caused by a likely pathogenic or pathogenic variant in the CTNNB1 gene. A systematic review was conducted to examine previous research that provided CTNNB1 syndrome patients, specifically those that described intellectual quotient, motor development, language impairments, behavioural problems and features of autism. Databases examined were PubMed and Scopus. The inclusion criteria were (a) reported human patients diagnosed with CTNNB1 syndrome by a genetic test; (b) were related to cognition, intelligence quotient, motor development, language impairment, behavioural problems or features of autism; (c) did not have another genetic diagnosis and (d) were written in Spanish or English. A total of 42 studies were included. Overall, the symptomatology described was very heterogeneous with varying degrees of impairment among patients. However, individuals reached most significant developmental milestones later than expected and with different degrees of impairment. The use of standardised methodology to assess cognitive and behavioural domains was scarce in most studies, and the vast majority did not include a specific assessment protocol based on the symptomatology of CTNNB1 syndrome individuals. In addition, only two adult patients were described in depth, which implies that there are many unknowns about the progression of the syndrome later in life. Therefore, future research should focus on increasing the sample assessed and count with a standardised protocol in order to characterise the cognitive and behavioural phenotype of CTNNB1 syndrome.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.